Leading psychedelic therapy education company among first approved to train licensed therapists under state's Natural Medicine Health Act implementation
MEDIA CONTACT:
Brad Burge
brad@integrationcommunications.com
Brad Burge
brad@integrationcommunications.com
Fluence, a leading educational platform for psychedelic therapy training, today announced that the Colorado Department of Regulatory Agencies (DORA) has approved its Professional Certificate in Psilocybin Clinical Facilitation program under the Natural Medicine Health Act. This approval positions Fluence among the first organizations authorized to train licensed psychotherapists for Colorado's groundbreaking psychedelic therapy program - Psilocybin Facilitation.
Colorado, ranked among states with the highest need for expanded mental health access, will begin allowing licensed facilitators to provide psilocybin facilitation in 2025. Fluence's comprehensive, accelerated certificate program for clinicians meets all DORA requirements for clinical facilitator training, including 130 hours of didactic training, 40 practicum hours, and 50 consultation hours across a minimum six-month period.
"This milestone represents a significant step forward in expanding access to psychedelic therapy in Colorado," said Elizabeth Nielson, Ph.D., co-founder of Fluence. "Our program builds on our experience educating over 8,000 clinicians and brings together leading researchers and experienced practitioners to provide theoretically grounded, research-based frameworks for psychedelic therapy practice."
Fluence's Colorado program is specifically designed for licensed psychotherapists, aligning with the state's innovative approach that allows mental health providers to incorporate natural medicine services within their existing practices. The curriculum combines live online and in-person training, featuring small group learning environments and individualized feedback from expert faculty with extensive clinical trial experience.
"Colorado's framework creates unique opportunities for licensed mental health professionals to expand their therapeutic toolbox," said Ingmar Gorman, Ph.D., co-founder of Fluence. "Our program ensures therapists receive comprehensive training that prioritizes both safety and efficacy, supporting Colorado's commitment to addressing its mental health crisis through evidence-based approaches."
The training program is now open for enrollment in alignment of the state's 2025 implementation timeline. Fluence's certificate program prepares clinicians to:
Colorado, ranked among states with the highest need for expanded mental health access, will begin allowing licensed facilitators to provide psilocybin facilitation in 2025. Fluence's comprehensive, accelerated certificate program for clinicians meets all DORA requirements for clinical facilitator training, including 130 hours of didactic training, 40 practicum hours, and 50 consultation hours across a minimum six-month period.
"This milestone represents a significant step forward in expanding access to psychedelic therapy in Colorado," said Elizabeth Nielson, Ph.D., co-founder of Fluence. "Our program builds on our experience educating over 8,000 clinicians and brings together leading researchers and experienced practitioners to provide theoretically grounded, research-based frameworks for psychedelic therapy practice."
Fluence's Colorado program is specifically designed for licensed psychotherapists, aligning with the state's innovative approach that allows mental health providers to incorporate natural medicine services within their existing practices. The curriculum combines live online and in-person training, featuring small group learning environments and individualized feedback from expert faculty with extensive clinical trial experience.
"Colorado's framework creates unique opportunities for licensed mental health professionals to expand their therapeutic toolbox," said Ingmar Gorman, Ph.D., co-founder of Fluence. "Our program ensures therapists receive comprehensive training that prioritizes both safety and efficacy, supporting Colorado's commitment to addressing its mental health crisis through evidence-based approaches."
The training program is now open for enrollment in alignment of the state's 2025 implementation timeline. Fluence's certificate program prepares clinicians to:
- Conduct thorough safety screenings and risk assessments
- Facilitate preparation, administration, and integration sessions
- Apply evidence-based frameworks for psilocybin-assisted therapy
- Comply with the regulatory requirements of Colorado's Natural Medicine Health Act
This approval builds on Fluence's track record of developing state-approved training programs, including their Oregon Health Authority-approved Certificate in Psilocybin-Assisted Therapy. Fluence continues to collaborate with leading research organizations and maintains high standards for professional education in psychedelic therapy.
Licensed psychotherapists can enroll now!
Licensed psychotherapists can enroll now!
About Fluence
Founded in 2019 by Elizabeth Nielson, PhD, and Ingmar Gorman, PhD, Fluence is an industry leader in psychedelic therapy training, having educated over 8,000 clinicians and counselors. The company provides comprehensive training programs and collaborates with major research organizations to advance psychedelic therapy through evidence-based practices.
